Medistep Healthcare (NSE:MEDISTEP) ROCE %: 38.91% (As of Mar. 2025)


NSE:MEDISTEP Medistep Healthcare Ltd NSE:MEDISTEP
19 GF Score
Price ₹18.00
! 2 Warning Signs
View Full Analysis

What is Medistep Healthcare ROCE %?

Medistep Healthcare NSE:MEDISTEP -9.55% 19 ROCE % is 38.91% as of Mar. 2025. GuruFocus rates NSE:MEDISTEP with a GF Score™ of 19/100. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medistep Healthcare's annualized ROCE % for the quarter that ended in Mar. 2025 was 38.91%.

Medistep Healthcare  (NSE:MEDISTEP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medistep Healthcare ROCE % Related Terms

Medistep Healthcare ROCE % Historical Data

* Premium members only.

The historical data trend for Medistep Healthcare's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medistep Healthcare ROCE % Chart

Medistep Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25
ROCE %
25.65 109.62 69.15 38.91

Medistep Healthcare Semi-Annual Data
Mar22 Mar23 Mar24 Mar25
ROCE % 25.65 109.62 69.15 38.91
NSE:MEDISTEP
19GF Score
Medistep Healthcare Ltd NSE:MEDISTEP
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medistep Healthcare ROCE % Calculation

Medistep Healthcare's annualized ROCE % for the fiscal year that ended in Mar. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=55.69/( ( (149.563 - 31.869) + (229.882 - 61.313) )/ 2 )
=55.69/( (117.694+168.569)/ 2 )
=55.69/143.1315
=38.91 %

Medistep Healthcare's ROCE % of for the quarter that ended in Mar. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2025 )  (Q: Mar. 2024 )(Q: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2025 )  (Q: Mar. 2024 )(Q: Mar. 2025 )
=55.69/( ( (149.563 - 31.869) + (229.882 - 61.313) )/ 2 )
=55.69/( ( 117.694 + 168.569 )/ 2 )
=55.69/143.1315
=38.91 %

(1) Note: The EBIT data used here is one times the annual (Mar. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 38.91% mean?
Medistep Healthcare (NSE:MEDISTEP) has a ROCE % of 38.91% as of Mar. 2025.
Is Medistep Healthcare's ROCE % too high?
Medistep Healthcare's current ROCE % is 38.91%. The Medical Distribution industry median ROCE % is 9.09. Medistep Healthcare's value of 38.91% is 328.1% above this industry median. Overall, Medistep Healthcare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medistep Healthcare's ROCE % compare to MCK and CAH?
Medistep Healthcare's ROCE % of 38.91% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 9.09. Medistep Healthcare's value of 38.91% is 328.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 9.09, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medistep Healthcare's current ROCE % of 38.91% is 328.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 9.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medistep Healthcare's current ROCE % is 38.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistep Healthcare stock overvalued right now?
Medistep Healthcare (NSE:MEDISTEP) has a current ROCE % of 38.91%. The current ROCE % is 38.91% and 328.1% above the Medical Distribution industry median of 9.09. Medistep Healthcare's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Medistep Healthcare (NSE:MEDISTEP), the current ROCE % is 38.91% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medistep Healthcare Business Description

Address National Highway 8, 05, S. No-245/B, Plot-19, T.P.S. 56, Free Way Trade Center, Near A-One Hotel, Narol Gam, Narol, Daskroi, Ahmadabad, GJ, IND, 382405
Medistep Healthcare Ltd operates in the pharmaceutical and healthcare product sectors. Its business includes manufacturing intimate care and hygiene products such as sanitary pads, as well as nutraceutical products like energy powders. The company also trades a variety of pharmaceutical, surgical, and medical equipment products. Medistep Healthcare's operations focus mainly on the western region of India, particularly in Gujarat. Its Core business activity is divided into the following categories: a) Trading of Pharmaceutical & Surgical products, b) Trading & Manufacturing of Nutraceuticals and Intimate care & hygiene products. The company generates the majority of its revenue from Trading and distribution.
19GF Score

Get the complete analysis for NSE:MEDISTEP

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹18.00
Price